Dvoretskova, E.* ; Ho, M.C.* ; Kittke, V. ; Neuhaus, F.* ; Vitali, I.* ; Lam, D.D. ; Delgado, I.* ; Feng, C.* ; Torres, M.* ; Winkelmann, J. ; Mayer, C.*
Spatial enhancer activation influences inhibitory neuron identity during mouse embryonic development.
Nat. Neurosci. 27, 862-872 (2024)
The mammalian telencephalon contains distinct GABAergic projection neuron and interneuron types, originating in the germinal zone of the embryonic basal ganglia. How genetic information in the germinal zone determines cell types is unclear. Here we use a combination of in vivo CRISPR perturbation, lineage tracing and ChIP-sequencing analyses and show that the transcription factor MEIS2 favors the development of projection neurons by binding enhancer regions in projection-neuron-specific genes during mouse embryonic development. MEIS2 requires the presence of the homeodomain transcription factor DLX5 to direct its functional activity toward the appropriate binding sites. In interneuron precursors, the transcription factor LHX6 represses the MEIS2-DLX5-dependent activation of projection-neuron-specific enhancers. Mutations of Meis2 result in decreased activation of regulatory enhancers, affecting GABAergic differentiation. We propose a differential binding model where the binding of transcription factors at cis-regulatory elements determines differential gene expression programs regulating cell fate specification in the mouse ganglionic eminence.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Ganglionic Eminence; Retinoic Acid; Dna-binding; Specification; Expression; Proteins; Fate
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
1097-6256
e-ISSN
1546-1726
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 27,
Issue: 5,
Pages: 862-872
Article Number: ,
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
Heidelberger Platz 3, Berlin, 14197, Germany
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30205 - Bioengineering and Digital Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-503200-001
Grants
European Commission
European Research Council (ERC) under the European Union
Max Planck Society
EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
Copyright
Erfassungsdatum
2024-05-23